title: The effects of donor specific transfusion and cyclosporine A on graft outcome.
authors.affiliation: Turkish Transplantation and Burn Foundation Hospital, Ankara, Turkey.
authors.forename: M
authors.initials: M
authors.lastname: Haberal
authors.forename: Z
authors.initials: Z
authors.lastname: Oner
authors.forename: N
authors.initials: N
authors.lastname: Aybasti
authors.forename: G
authors.initials: G
authors.lastname: Arslan
authors.forename: M
authors.initials: M
authors.lastname: Turan
authors.forename: N
authors.initials: N
authors.lastname: Bilgin
mesh_terms: D000328:Adult; D001782:Blood Donors; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D014019:Tissue Donors
chemical_list: D003524:Cyclosporins; D008775:Methylprednisolone